Chronic obstructive pulmonary disease (COPD) makes it hard to breathe. Narrowed airways can make you cough, wheeze, and feel short of breath. It can affect how you exercise, work, and do other daily ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca, in collaboration with Amgen, is ...

Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...

Personalized and effective delivery systems, including single-inhaler dry powder and novel nebulized devices, are transforming COPD treatment approaches. The high unmet medical need and growing ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

Patients with COPD are at increased risk for infections, making avoidance and effective treatments key in management.

Please provide your email address to receive an email when new articles are posted on . Remodeling may include more smooth muscle mass and epithelial cell shedding. Macrolides, vaccination and ...

Gordon Stewart-Harrison recalls his first experience with chronic obstructive pulmonary disease (COPD) when he was shoveling snow on his driveway. After just a few moments, he was completely out of ...

Among adults with undiagnosed respiratory symptoms, those with undiagnosed COPD and asthma vs. preserved ratio impaired or ...

Chronic obstructive pulmonary disease (COPD) and acute bronchitis both cause lung irritation and inflammation. They can trigger similar symptoms, including coughing, chest pain, and fatigue. Acute ...